Assessment of CNS effects of antiepileptic drugs by using quantitative EEG measures

Martin Salinsky, Barry Oken, Daniel Storzbach, Carl B. Dodrill

Research output: Contribution to journalArticle

48 Citations (Scopus)

Abstract

Purpose: Antiepileptic drugs (AEDs) can be associated with adverse neurologic effects including cognitive dysfunction. Objective methods for recognizing AED effects on the brain could be valuable for long-term management. We compared quantitative EEG measures and cognitive tests in a group of patients beginning or ending AED therapy. Methods: Subjects included 20 patients beginning AED therapy (AEDon), 12 patients stopping AED therapy (AEDoff), 33 patient controls receiving stable AED therapy (AEDco), and 73 healthy controls (Nco). All subjects underwent structured EEG recording and a cognitive test battery before change in AED dose and again 12-16 weeks later, >4 weeks after the last dose change. Four occipital EEG measures (peak frequency, median frequency, relative theta and delta power) were analyzed. Cognitive test changes were scored by using test-retest regression equations based on the Nco subjects. Wilcoxon tests were used for two-group comparisons. Results: AEDons had a significant decrease, and AEDoffs, a significant increase in the peak frequency of the EEG rhythm, as compared with controls. Results for median frequency and theta power were similar. Change in the EEG peak frequency correlated with an aggregate cognitive change measure (r2 = 0.71; p <0.001), individual cognitive measures, and subjective complaints. Of the combined AEDon/AEDoff patients, 58% exceeded the 95% confidence interval for test-retest change in EEG peak frequency. Conclusions: Quantitative measures derived from the occipital EEG are sensitive to AEDs and correlate with AEDrelated cognitive effects and subjective complaints. Although this correlation does not indicate a direct relation, quantified EEG may be a practical measure of AED impact on the brain.

Original languageEnglish (US)
Pages (from-to)1042-1050
Number of pages9
JournalEpilepsia
Volume44
Issue number8
DOIs
StatePublished - Aug 1 2003

Fingerprint

Anticonvulsants
Electroencephalography
Drug Therapy
Brain
Nervous System
Confidence Intervals

Keywords

  • Antiepileptic drugs
  • Cognition
  • Electroencephalography
  • Epilepsy

ASJC Scopus subject areas

  • Clinical Neurology
  • Neuroscience(all)

Cite this

Assessment of CNS effects of antiepileptic drugs by using quantitative EEG measures. / Salinsky, Martin; Oken, Barry; Storzbach, Daniel; Dodrill, Carl B.

In: Epilepsia, Vol. 44, No. 8, 01.08.2003, p. 1042-1050.

Research output: Contribution to journalArticle

Salinsky, Martin ; Oken, Barry ; Storzbach, Daniel ; Dodrill, Carl B. / Assessment of CNS effects of antiepileptic drugs by using quantitative EEG measures. In: Epilepsia. 2003 ; Vol. 44, No. 8. pp. 1042-1050.
@article{2394f7b47fb34e7fb776048d950b3003,
title = "Assessment of CNS effects of antiepileptic drugs by using quantitative EEG measures",
abstract = "Purpose: Antiepileptic drugs (AEDs) can be associated with adverse neurologic effects including cognitive dysfunction. Objective methods for recognizing AED effects on the brain could be valuable for long-term management. We compared quantitative EEG measures and cognitive tests in a group of patients beginning or ending AED therapy. Methods: Subjects included 20 patients beginning AED therapy (AEDon), 12 patients stopping AED therapy (AEDoff), 33 patient controls receiving stable AED therapy (AEDco), and 73 healthy controls (Nco). All subjects underwent structured EEG recording and a cognitive test battery before change in AED dose and again 12-16 weeks later, >4 weeks after the last dose change. Four occipital EEG measures (peak frequency, median frequency, relative theta and delta power) were analyzed. Cognitive test changes were scored by using test-retest regression equations based on the Nco subjects. Wilcoxon tests were used for two-group comparisons. Results: AEDons had a significant decrease, and AEDoffs, a significant increase in the peak frequency of the EEG rhythm, as compared with controls. Results for median frequency and theta power were similar. Change in the EEG peak frequency correlated with an aggregate cognitive change measure (r2 = 0.71; p <0.001), individual cognitive measures, and subjective complaints. Of the combined AEDon/AEDoff patients, 58{\%} exceeded the 95{\%} confidence interval for test-retest change in EEG peak frequency. Conclusions: Quantitative measures derived from the occipital EEG are sensitive to AEDs and correlate with AEDrelated cognitive effects and subjective complaints. Although this correlation does not indicate a direct relation, quantified EEG may be a practical measure of AED impact on the brain.",
keywords = "Antiepileptic drugs, Cognition, Electroencephalography, Epilepsy",
author = "Martin Salinsky and Barry Oken and Daniel Storzbach and Dodrill, {Carl B.}",
year = "2003",
month = "8",
day = "1",
doi = "10.1046/j.1528-1157.2003.60602.x",
language = "English (US)",
volume = "44",
pages = "1042--1050",
journal = "Epilepsia",
issn = "0013-9580",
publisher = "Wiley-Blackwell",
number = "8",

}

TY - JOUR

T1 - Assessment of CNS effects of antiepileptic drugs by using quantitative EEG measures

AU - Salinsky, Martin

AU - Oken, Barry

AU - Storzbach, Daniel

AU - Dodrill, Carl B.

PY - 2003/8/1

Y1 - 2003/8/1

N2 - Purpose: Antiepileptic drugs (AEDs) can be associated with adverse neurologic effects including cognitive dysfunction. Objective methods for recognizing AED effects on the brain could be valuable for long-term management. We compared quantitative EEG measures and cognitive tests in a group of patients beginning or ending AED therapy. Methods: Subjects included 20 patients beginning AED therapy (AEDon), 12 patients stopping AED therapy (AEDoff), 33 patient controls receiving stable AED therapy (AEDco), and 73 healthy controls (Nco). All subjects underwent structured EEG recording and a cognitive test battery before change in AED dose and again 12-16 weeks later, >4 weeks after the last dose change. Four occipital EEG measures (peak frequency, median frequency, relative theta and delta power) were analyzed. Cognitive test changes were scored by using test-retest regression equations based on the Nco subjects. Wilcoxon tests were used for two-group comparisons. Results: AEDons had a significant decrease, and AEDoffs, a significant increase in the peak frequency of the EEG rhythm, as compared with controls. Results for median frequency and theta power were similar. Change in the EEG peak frequency correlated with an aggregate cognitive change measure (r2 = 0.71; p <0.001), individual cognitive measures, and subjective complaints. Of the combined AEDon/AEDoff patients, 58% exceeded the 95% confidence interval for test-retest change in EEG peak frequency. Conclusions: Quantitative measures derived from the occipital EEG are sensitive to AEDs and correlate with AEDrelated cognitive effects and subjective complaints. Although this correlation does not indicate a direct relation, quantified EEG may be a practical measure of AED impact on the brain.

AB - Purpose: Antiepileptic drugs (AEDs) can be associated with adverse neurologic effects including cognitive dysfunction. Objective methods for recognizing AED effects on the brain could be valuable for long-term management. We compared quantitative EEG measures and cognitive tests in a group of patients beginning or ending AED therapy. Methods: Subjects included 20 patients beginning AED therapy (AEDon), 12 patients stopping AED therapy (AEDoff), 33 patient controls receiving stable AED therapy (AEDco), and 73 healthy controls (Nco). All subjects underwent structured EEG recording and a cognitive test battery before change in AED dose and again 12-16 weeks later, >4 weeks after the last dose change. Four occipital EEG measures (peak frequency, median frequency, relative theta and delta power) were analyzed. Cognitive test changes were scored by using test-retest regression equations based on the Nco subjects. Wilcoxon tests were used for two-group comparisons. Results: AEDons had a significant decrease, and AEDoffs, a significant increase in the peak frequency of the EEG rhythm, as compared with controls. Results for median frequency and theta power were similar. Change in the EEG peak frequency correlated with an aggregate cognitive change measure (r2 = 0.71; p <0.001), individual cognitive measures, and subjective complaints. Of the combined AEDon/AEDoff patients, 58% exceeded the 95% confidence interval for test-retest change in EEG peak frequency. Conclusions: Quantitative measures derived from the occipital EEG are sensitive to AEDs and correlate with AEDrelated cognitive effects and subjective complaints. Although this correlation does not indicate a direct relation, quantified EEG may be a practical measure of AED impact on the brain.

KW - Antiepileptic drugs

KW - Cognition

KW - Electroencephalography

KW - Epilepsy

UR - http://www.scopus.com/inward/record.url?scp=0042071480&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0042071480&partnerID=8YFLogxK

U2 - 10.1046/j.1528-1157.2003.60602.x

DO - 10.1046/j.1528-1157.2003.60602.x

M3 - Article

C2 - 12887435

AN - SCOPUS:0042071480

VL - 44

SP - 1042

EP - 1050

JO - Epilepsia

JF - Epilepsia

SN - 0013-9580

IS - 8

ER -